| Annual Financials | Mar 2026 |
| Revenue | 214.16 |
| Expenses | 189.83 |
| Other Income | 0.27 |
| Total Revenue | 214.43 |
| Profit Before Tax | 24.59 |
| Net Profit | 18.45 |


The company operates a comprehensive healthcare ecosystem catering to hospitals, clinics, diagnostic laboratories, IVD companies, and pharmaceutical companies. The company focuses on time-sensitive and compliance critical logistics, supported by cold chain enabled network and multimodal transportation including road, air, and onboard courier services with trained workforce across multiple cities.
The company has a client base providing repeated business with revenue generated from around 280 domestic customers including 38 customers who have associated with the company for the last three continuous years. The company maintains healthy relationships through regular communication and flexible logistics solutions ensuring samples reach destinations on time and in optimal condition.
The company's promoters, Chairman and Managing Director Tarun Sharma and Whole Time Director & Chief Financial Officer Karan Sharma have over 12 years and 9 years of experience each in the logistics industry. Their expertise lies in strategic planning, team management, business development, business strategy, sales management and competitive analysis.
The company derives a significant portion of revenue from its top 10 customers (81.76% in Fiscal 2026) without firm commitments. The loss of any major customers could materially affect business operations and financial performance.
The company's business is dependent on diagnostic and healthcare companies' testing volumes and outsourcing requirements. Any reduction in testing volumes or adverse sector developments could materially affect business and results of operations.
The company is exposed to risks of loss, damage, contamination or delay in transportation of diagnostic samples. Such incidents could result in client claims, financial liabilities and reputational harm affecting business operations.
The company proposes to invest in Credent Healthcare Private Limited to meet its working capital requirements, primarily for trade receivables and funding day-to-day operations.
The company plans to invest in Credent Healthcare Private Limited to finance capital expenditure for procuring sonography machines and digital X-ray machines for diagnostic services.
The company proposes to utilize funds towards funding long-term working capital requirements for executing increased order volumes, high inventory levels, high debtors, and advance payments to suppliers.
The company intends to repay in part or full certain borrowings availed from lenders to reduce outstanding indebtedness and debt servicing costs.
The company will utilize funds for general corporate purposes including meeting operating expenses, initial development costs, strengthening business development and marketing capabilities, and meeting exigencies.
| Annual Financials | Mar 2026 |
| Revenue | 214.16 |
| Expenses | 189.83 |
| Other Income | 0.27 |
| Total Revenue | 214.43 |
| Profit Before Tax | 24.59 |
| Net Profit | 18.45 |
| Balance Sheet | Mar 2026 |
| Total Assets | 81.57 |
| Current Assets | 63.05 |
| Fixed Assets | 18.52 |
| Total Equity & Liabilities | 81.57 |
| Total Liabilities | 37.78 |
| Current Liabilities | 30.63 |
| Non Current Liabilities | 7.15 |
| Total Equity | 43.79 |
| Cash Flow | Mar 2026 |
| Net Cash Flow | 1.25 |
| Investing Activities | -10.78 |
| Operating Activities | -6.62 |
| Financing Activities | 18.66 |